The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AN2 THERAPEUTICS INC | COM | 037326105 | 31,598 | 23,234 | SH | SOLE | 23,234 | 0 | 0 | |||
| BARNWELL INDS INC | COM | 068221100 | 24,300 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | |||
| CLARUS CORP NEW | COM | 18270P109 | 83,250 | 22,200 | SH | SOLE | 22,200 | 0 | 0 | |||
| DESWELL INDS INC | COM | 250639101 | 23,550 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | |||
| ENZO BIOCHEM INC | COM | 294100102 | 57,832 | 156,303 | SH | SOLE | 156,303 | 0 | 0 | |||
| ESSA PHARMA INC | COM NEW | 29668H708 | 50,086 | 31,700 | SH | SOLE | 31,700 | 0 | 0 | |||
| ISHARES TR | MSCI EAFE ETF | 464287465 | 38,086,180 | 466,000 | SH | SOLE | 466,000 | 0 | 0 | |||
| LAVA THERAPEUTICS NV | SHS | N51517105 | 29,210 | 23,000 | SH | SOLE | 23,000 | 0 | 0 | |||
| LGL GROUP INC | *W EXP 11/16/202 | 50186A132 | 8,381 | 26,200 | SH | SOLE | 26,200 | 0 | 0 | |||
| LIFECORE BIOMEDICAL INC | COM | 514766104 | 138,688 | 19,700 | SH | SOLE | 19,700 | 0 | 0 | |||
| PRESIDIO PPTY TR INC | COM CL A | 74102L303 | 77,122 | 134,125 | SH | SOLE | 134,125 | 0 | 0 | |||
| SPDR S&P 500 ETF TR | TR UNIT | 78462F103 | 64,466,901 | 115,245 | SH | SOLE | 115,245 | 0 | 0 | |||
| WETOUCH TECHNOLOGY INC | COM NEW | 961881208 | 98,533 | 67,954 | SH | SOLE | 67,954 | 0 | 0 | |||
| XYLO TECHNOLOGIES LTD | SPONSORED ADS | 58471G508 | 127,950 | 26,059 | SH | SOLE | 26,059 | 0 | 0 | |||